Moderna (MRNA) Reports In-Line Q1 EPS

Moderna (NASDAQ: MRNA) reported Q1 EPS of ($0.35), in-line with the analyst estimate of ($0.35). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $17.09 million.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
• SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds